sodium-pertechnetate-tc-99m and Urinary-Tract-Infections

sodium-pertechnetate-tc-99m has been researched along with Urinary-Tract-Infections* in 3 studies

Other Studies

3 other study(ies) available for sodium-pertechnetate-tc-99m and Urinary-Tract-Infections

ArticleYear
Neonates with extra-renal pelvis: the first 2 years.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:6

    Extra-renal pelvis (ERpel) is a common ultrasonographic finding among neonates who have undergone recurrent ultrasound examinations for a better definition of prenatal renal pelvic dilatation. This study tries to determine whether or not ERpel has important prognostic implications. Seventy-nine neonates (17 female) were examined. All had a diagnosis of prenatal renal pelvis dilatation, which was shown by postnatal ultrasound to be ERpel. Sixty ERpel neonates were examined 1.5 months to 2.5 months after the ultrasound (US) diagnosis by both Tc-99m diethylene triamine penta-acetic acid (DPTA) dynamic renal scanning and (99m)Tc-pertechnetate direct cystography. Clinical assessment, urine cultures and renal ultrasound follow-up were maintained for 2 years. The proportion of urinary tract infections (UTIs) in patients with ERpel was compared with that of the total neonatal and infantile population with normal US scans in the region of our hospital. Associated minor congenital malformations were found in 12 of 79 neonates (15.2%). Four had a family history of ERpel. Among 60 neonates who underwent renal scanning, 36 (60%) were found to have urinary retention in the collecting system. Another nine (15%) had vesico-ureteral (VU) reflux, of which seven had urinary retention. Fifteen (25%) showed normal isotope imaging. Urinary tract infection was diagnosed in 16 ERpel neonates in whom only one exhibited VU reflux (grade 2). The incidence of neonatal UTI in the ERpel group was more than that of either neonatal or infantile UTI in those with normal US scans in the local population (20.2% vs 1.2% and 4.3%, respectively). Fifty-three infants completed a 2-year follow-up. Repeat renal ultrasonography indicated that one infant (1.8%) had developed bilateral hydronephrosis, 12 (22.6%) had unchanged findings, 18 (40%) showed an improvement (decrease of ERpel width or resolution in one side) and, in 22 (41.5%) infants, the condition had resolved. No clinical or kidney function deterioration was observed. Seven patients (13.2%) each had one episode of UTI during the 2-year follow-up period; none of them had VU reflux. Neonatal ERpel is more frequent in male infants. It is associated with greater rates of minor congenital malformations, VU reflux and UTI than in the general population of the same ages. The increased UTI incidence is not attributed to VU reflux.

    Topics: Abnormalities, Multiple; Female; Follow-Up Studies; Humans; Incidence; Infant, Newborn; Kidney Pelvis; Male; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sex Distribution; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Pentetate; Ultrasonography; Urinary Bladder; Urinary Retention; Urinary Tract Infections; Vesico-Ureteral Reflux

2005
Ventilation-perfusion lung imaging in nitrofurantoin-related pulmonary reaction.
    Clinical nuclear medicine, 1992, Volume: 17, Issue:2

    A woman with a history of multiple drug allergies was admitted for cough and dyspnea. She had been taking nitrofurantoin for 10 days, was febrile, and had a rash on the trunk and extremities. A chest radiograph revealed right-sided pleural effusion and basal markings. Because of suspected nitrofurantoin-related pulmonary reaction, the medication was discontinued and the patient was started on an H2-blocker and intravenous corticosteroids. She improved clinically, and within 24 hours a radiograph revealed that her chest had largely cleared. Restricted distribution of radioxenon, seen initially on a ventilation lung scan, also reverted to near normal by the follow-up. The first perfusion lung scan showed multiple but nonspecific changes; this also came back to near normal. The nitrofurantoin-related pulmonary reaction should be considered in patients who present with pulmonary signs/symptoms while on the medication.

    Topics: Drug Hypersensitivity; Female; Humans; Lung; Middle Aged; Nitrofurantoin; Pleural Effusion; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Urinary Tract Infections; Ventilation-Perfusion Ratio; Xenon Radioisotopes

1992
Altered distribution of technetium-99m sodium pertechnetate associated with antimicrobial therapy.
    Clinical nuclear medicine, 1985, Volume: 10, Issue:12

    Three patients underwent brain scanning for evaluation of central nervous system disease and were simultaneously treated for infectious diseases unrelated to the central nervous process. All revealed intense vascular pooling on their brain images. The imaging studies had been performed following the administration of Tc-99m pertechnetate. None of the patients had prior nuclear medicine examinations to suggest the causal effect of stannous ion as a source of interference. All of the patients were on combination antimicrobial drugs: two on sulfamethoxazole and trimethoprim, and one on isoniazid and ethambutol. One patient revealed 75% Tc-99m red cell tagging. Another patient's repeat brain scan with Tc-99m DTPA revealed normal distribution. Our findings suggest that patients on antimicrobial combination drug regimens who require brain scans should be imaged routinely with agents other than Tc-99m.

    Topics: Aged; Anti-Bacterial Agents; Brain; Central Nervous System Diseases; Drug Interactions; Erythrocytes; Female; Humans; Isotope Labeling; Male; Middle Aged; Pentetic Acid; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium; Technetium Tc 99m Pentetate; Tissue Distribution; Urinary Tract Infections

1985